STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLLS
  4. [EFFECT] Cellectis S.A. American SEC Filing

[EFFECT] Cellectis S.A. American SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
-
-
-
-
-
Positive
  • None.
Negative
  • None.
-
-
-
-
-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: F-3
CIK: 0001627281
Company Name: Cellectis S.A.
File Number: 333-288491

Source: View Original Filing on SEC EDGAR

Stock CLLS logo
Cellectis

NASDAQ:CLLS

CLLS Rankings

#6108 Ranked by Market Cap
N/A Ranked by Dividends

CLLS Latest News

Jul 4, 2025
Monthly information on share capital and company voting rights
Jun 26, 2025
Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025
Jun 5, 2025
Monthly information on share capital and company voting rights
May 21, 2025
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
May 12, 2025
Cellectis Reports Financial Results for the First Quarter 2025

CLLS Latest SEC Filings

Jul 2, 2025
[F-3] Cellectis S.A. American Foreign Issuer Shelf Registration
Jun 26, 2025
[6-K] Cellectis S.A. American Current Report (Foreign Issuer)
Jun 26, 2025
[6-K] Cellectis S.A. American Current Report (Foreign Issuer)

CLLS Stock Data

160.52M
69.50M
3.87%
20.71%
0.24%
Biotechnology
Healthcare
Link
France
Paris